title: Seizure Reduction with Fluoxetine in Dravet Syndrome.
abstract: An adult woman with Dravet syndrome (documented SCN1A mutation) experienced a marked reduction in seizures when treated with the selective serotonin reuptake inhibitor (SSRI) fluoxetine. The seizure reduction may be partly to reductions associated with aging in Dravet patients, but it appears to be due at least in part to the fluoxetine. A prior preliminary study reported that fenfluramine reduces seizures in patients with Dravet syndrome. Fenfluramine may produce this effect by increasing serotonin brain levels, and SSRIs have been found to possess antiepileptic properties in animal models of epilepsy. Given the known cardiac risks of fenfluramine, consideration of randomized clinical trials with SSRIs should be considered in Dravet syndrome and other epilepsies.
authors: Department of Neurology & Neurological Sciences, Stanford University, Stanford CA.
authors: Kimford J
authors: KJ
authors: Meador
keywords: Dravet syndrome; antidepressant; epilepsy; seizures; selective serotonin reuptake inhibitor; serotonin